[go: up one dir, main page]

AU3167095A - Pth or pthrp antagonists - Google Patents

Pth or pthrp antagonists

Info

Publication number
AU3167095A
AU3167095A AU31670/95A AU3167095A AU3167095A AU 3167095 A AU3167095 A AU 3167095A AU 31670/95 A AU31670/95 A AU 31670/95A AU 3167095 A AU3167095 A AU 3167095A AU 3167095 A AU3167095 A AU 3167095A
Authority
AU
Australia
Prior art keywords
pth
pthrp
antagonists
pthrp antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31670/95A
Inventor
Francois Cardinaux
Jean Honore M. Feyen
Rainer Gamse
Frank Otto Gombert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9415255A external-priority patent/GB9415255D0/en
Priority claimed from GB9415254A external-priority patent/GB9415254D0/en
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU3167095A publication Critical patent/AU3167095A/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Amend patent request/document other than specification (104) Assignors: SANDOZ LTD.
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AU31670/95A 1994-07-28 1995-07-27 Pth or pthrp antagonists Abandoned AU3167095A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9415255A GB9415255D0 (en) 1994-07-28 1994-07-28 Organic compounds
GB9415255 1994-07-28
GB9415254A GB9415254D0 (en) 1994-07-28 1994-07-28 Organic compounds
GB9415254 1994-07-28
PCT/EP1995/002993 WO1996003437A1 (en) 1994-07-28 1995-07-27 PTH OR PTHrP ANTAGONISTS

Publications (1)

Publication Number Publication Date
AU3167095A true AU3167095A (en) 1996-02-22

Family

ID=26305357

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31670/95A Abandoned AU3167095A (en) 1994-07-28 1995-07-27 Pth or pthrp antagonists

Country Status (15)

Country Link
EP (1) EP0773958A1 (en)
JP (1) JPH10502091A (en)
AU (1) AU3167095A (en)
BR (1) BR9508433A (en)
CA (1) CA2192787A1 (en)
CO (1) CO4410206A1 (en)
CZ (1) CZ23397A3 (en)
FI (1) FI970168A0 (en)
HU (1) HUT77979A (en)
IL (1) IL114736A0 (en)
NO (1) NO970356L (en)
PL (1) PL318017A1 (en)
SK (1) SK12097A3 (en)
TR (1) TR199500915A2 (en)
WO (1) WO1996003437A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW505654B (en) 1996-07-30 2002-10-11 Hoffmann La Roche Synthesis of analogs of PTH and PTHrP
DE69734157T2 (en) * 1996-07-31 2006-07-13 The General Hospital Corp., Boston PARATHYROIDHORMONE-RELATED PEPTIDE ANALOG
CZ106299A3 (en) 1996-09-26 1999-08-11 Chugai Seiyaku Kabushiki Kaisha Antibodies to human parathyroid hormone related protein
HUP0003349A3 (en) 1997-05-14 2001-12-28 Aventis Pharmaceuticals Inc Co Peptide parathyroid hormone analogs, pharmaceutical compositions comprising thereof and their use
KR100508338B1 (en) 1997-05-15 2005-08-17 츄가이 세이야꾸 가부시키가이샤 Cachexia Remedy
TWI255718B (en) 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration
CA2373885A1 (en) * 1999-07-02 2001-01-11 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for diseases caused by pth or pthrp
CN1399557A (en) * 1999-07-06 2003-02-26 中外制药株式会社 Remedies for drug-resistant hypercalcemia
ES2250187T3 (en) * 1999-09-20 2006-04-16 Eli Lilly And Company USE OF THE PARTIROID HORMONE TO REDUCE THE RISK OF CANCER.
US20030049211A1 (en) * 2000-01-25 2003-03-13 Atsuhiko Kato Remedies and preventives for dental diseases
WO2001064249A1 (en) * 2000-02-28 2001-09-07 Chugai Seiyaku Kabushiki Kaisha Tissue decomposition inhibitor
ATE420661T1 (en) 2000-04-28 2009-01-15 Chugai Pharmaceutical Co Ltd CELL PROLIFERATION INHIBITORS
WO2002013865A1 (en) * 2000-08-16 2002-02-21 Chugai Seiyaku Kabushiki Kaisha Agents for ameliorating symptoms caused by joint diseases
US8568737B2 (en) 2007-08-01 2013-10-29 The General Hospital Corporation Screening methods using G-protein coupled receptors and related compositions
CN103002906B (en) 2010-05-13 2017-12-29 总医院有限公司 Parathyroid hormone analogs and their applications

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2040264A1 (en) * 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
EP0539491A1 (en) * 1990-07-13 1993-05-05 The Regents Of The University Of California PARATHYROID HORMONE ANALOGUES MODIFIED AT POSITIONS 3, 6 or 9
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments

Also Published As

Publication number Publication date
CA2192787A1 (en) 1996-02-08
NO970356D0 (en) 1997-01-28
JPH10502091A (en) 1998-02-24
MX9700446A (en) 1998-06-28
FI970168A7 (en) 1997-01-15
TR199500915A2 (en) 1996-06-21
WO1996003437A1 (en) 1996-02-08
EP0773958A1 (en) 1997-05-21
CO4410206A1 (en) 1997-01-09
SK12097A3 (en) 1997-08-06
IL114736A0 (en) 1995-11-27
BR9508433A (en) 1998-07-14
PL318017A1 (en) 1997-05-12
HUT77979A (en) 1999-01-28
FI970168L (en) 1997-01-15
FI970168A0 (en) 1997-01-15
NO970356L (en) 1997-01-28
CZ23397A3 (en) 1997-07-16

Similar Documents

Publication Publication Date Title
AU2524995A (en) Neurokinine (tachykinine) antagonists
AU2356495A (en) Chemical feeder
AU4036895A (en) Substituted 1H-imidazoles
ZA9610858B (en) Heteroclyclic compounds.
HU9601176D0 (en) Adhesion-receptor antagonists
AU3994995A (en) Sprayer
AU3190495A (en) Transmitter-receiver
AU6856796A (en) Des-arg9-bk antagonists
AU3567195A (en) Neurokinin antagonists
AU3167095A (en) Pth or pthrp antagonists
AU2844595A (en) Substituted biphenyloxazolines
HU9503191D0 (en) Adhesion-receptor antagonists
AU3554995A (en) Antipicornaviral agents
AU1574995A (en) Tachykinins antagonists
ZA964560B (en) Anit-viral compounds.
AU3856295A (en) Endothelin antagonists
ZA969560B (en) Substituted 1-methyl-3-phenylpyrazoles.
AU4081996A (en) The treefeedah
GB9507688D0 (en) The thomobilizer
AU2053399A (en) Inductive component
AUPN725095A0 (en) The backstrap
AUPM701694A0 (en) Improved biocide
ZA967181B (en) Substituted Benzylaminopiperidine Compounds.
AUPN439995A0 (en) Improved biocide
AU131279S (en) Construction component